Company Overview and News

87
Tracking Dan Loeb's Third Point Portfolio - Q2 2018 Update

2018-08-12 seekingalpha - 4
Dan Loeb's 13F portfolio value increased from $13.32B to $14.35B this quarter. The number of positions decreased from 40 to 38.
ATHTF STZ.B TWX CRM DOW DOV MELI PBF TPRE WP KDMN STZ UTX BKI TWC PVH DVMT FPAC.U GOOGL MSFT APY MHK TPNTF GRBK FB DOV.WI LEN NXPI PYPL NFLX BAX GOOG LEN.B MPC PAGS ADBE SPGI EGN MON ICE SHY CWH EA WYNN ANTM DWDP BID BLK V DHR ANTX

26
Michael Dell's Lesson for Elon Musk: Going Private Isn't a Cure-All - Bloomberg

2018-08-08 bloomberg - 1
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BGX DVMT DTK EMC BGLF BX PVTL VMW SCWX BGB

8
DVMT / Dell Technologies Inc. 425 (Prospectus)

2018-08-08 sec.gov
425 Filed by Dell Technologies Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 19
DVMT

8
How Singapore can unlock the potential of its women entrepreneurs

2018-08-08 theedgemarkets
SINGAPORE (Aug 8): Singapore may be the only Asian city to make it to Dell’s global top 10 list for the ability to foster high-potential women entrepreneurs (HPWE), but still has room for improvement in areas such as work-life balance and hiring policies.
DVMT

8
Elon Musk Says He’s Considering a Move to Take Tesla Private - The New York Times

2018-08-07 nytimes
Lamenting the pressures of answering to the stock market, Elon Musk, Tesla’s chief executive, said Tuesday that he was considering taking the company private.
DVMT NYTAB

9
Dell Projects Revenue Boost in Pitch for Tracking-Stock Buyout - Bloomberg

2018-08-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DVMT VMW

8
DVMT / Dell Technologies Inc. S-4

2018-08-06 sec.gov
S-4 Table of Contents As filed with the Securities and Exchange Commission on August 6, 2018 Registration No. 333- <
DVMT

8
DVMT / Dell Technologies Inc. 425 (Prospectus)

2018-08-03 sec.gov
425 Filed by Dell Technologies Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934
DVMT

9
Dell thinks it knows what it’s worth. Investors may need more convincing

2018-07-31 malaymail
SAN FRANCISCO, July 31 — Michael Dell thinks he knows what his namesake company is worth, and he isn’t budging.
DB DVMT EMC VMW

11
Turning Around an Old-School Tech Company - Bloomberg

2018-07-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DVMT CSCO HPQ HPE

20
Cray: A Solid Tech Company For Your Long-Term Portfolio

2018-07-19 seekingalpha
Cray's stock has been under pressure during the last two years, following a shrinking of its super computer business.
IBM DVMT STX MSFT CRAY HPE

9
SecureWorks (SCWX) Jumps: Stock Rises 8.4%

2018-07-17 zacks
SecureWorks Corp. (SCWX - Free Report) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.54 to $12.72 in the past one-month time frame.
DVMT SCWX SGH

10
The Dell-Discount

2018-07-16 seekingalpha
DVMT-shareholders have to take this Dell-discount into account in order to determine the best way forward.
LSXMB BATRK DVMT FWONB LSXMA FWONK BATRB LSXMK BATRR VMW BATRA FWONA

14
Titans of Junk: Behind the Debt Binge That Now Threatens Markets

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VWR SGMS THI EMC BLL DVMT 2007 JEF MS

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 24703L103